Recent Quarter Total Invested
$11.40 M
Recent Quarter Institutional Ownership Percentage
22.81%
Total Invested of Last Quarter
$12.35 M
Ownership Percentage of Last Quarter
46.69%
Xilio Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2024 | 4.57 M | $3.60 M | 20.64% | 7.20% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 3.00 M | $2.37 M | 0.00% | 4.73% |
| MORGAN STANLEY | 11/14/2024 | 1.52 M | $1.20 M | 36.79% | 2.40% |
| RIVERVEST VENTURE MANAGEMENT LLC | 10/30/2024 | 1.44 M | $1.14 M | 0.00% | 2.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 338,192 | $266,420 | 84.95% | 0.53% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 272,486 | $214,637 | 0.00% | 0.43% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 266,300 | $209,765 | -9.73% | 0.42% |
| FIL LTD | 11/13/2024 | 218,705 | $172,274 | 0.00% | 0.34% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 75,624 | $59,569 | 100.00% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 71,081 | $55,991 | 0.00% | 0.11% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 44,445 | $35,009 | 234.90% | 0.07% |
| STATE STREET CORP | 11/14/2024 | 43,390 | $34,178 | 0.00% | 0.07% |
| SEVENBRIDGE FINANCIAL GROUP, LLC | 11/12/2024 | 41,000 | $44,690 | 0.00% | 0.06% |
| RAYMOND JAMES & ASSOCIATES | 10/18/2024 | 38,825 | $30,582 | 0.00% | 0.06% |
| ENGINEERS GATE MANAGER LP | 11/14/2024 | 32,752 | $25,799 | 100.00% | 0.05% |
| MARINER, LLC | 11/13/2024 | 25,317 | $19,942 | 100.00% | 0.04% |
| XTX TOPCO LTD | 11/14/2024 | 23,862 | $18,796 | -28.32% | 0.04% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 20,655 | $16,270 | 69.23% | 0.03% |
| AVANTAX PLANNING PARTNERS, INC. | 11/14/2024 | 20,483 | $16,134 | -18.07% | 0.03% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/14/2024 | 20,000 | $15,754 | 100.00% | 0.03% |
| UBS GROUP AG | 11/14/2024 | 15,733 | $12,397 | 7,727.36% | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 10,389 | $8,183 | 100.00% | 0.02% |
| DUNHILL FINANCIAL, LLC | 11/15/2024 | 10,274 | $8,093 | 0.00% | 0.02% |
| PINNACLE FINANCIAL GROUP, LLC / IL | 11/12/2024 | 10,000 | $7,877 | 0.00% | 0.02% |
| KEY FINANCIAL INC | 10/29/2024 | 830 | $654 | 0.00% | 0.00% |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | 10/29/2024 | 310 | $245 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 266 | $209 | -61.56% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 75 | $59 | 27.12% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Xilio Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of XLO shares?
During the previous two years, 35 institutional investors and hedge funds held shares of Xilio Therapeutics, Inc.. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 4.57 M
Rock Springs Capital Management LP: 3 M
MORGAN STANLEY: 1.52 M
RiverVest Venture Management LLC: 1.44 M
GEODE CAPITAL MANAGEMENT, LLC: 338,192
BALYASNY ASSET MANAGEMENT L.P.: 272,486
-
What percentage of Xilio Therapeutics, Inc. stock is owned by institutional investors?
22.81% of Xilio Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at XLO ?
Institutional investors have bought a total of 13.12 M shares in the last 24 months. This purchase volume represents approximately $11.81 M in transactions.